AI

Category

Digital Health Technology Company Tempus Enrolls 2,500 Oncologists for Tempus Integrated Molecular Evaluation (TIME) Trial

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a milestone in fully enrolling 2,500 oncologists into its Tempus Integrated Molecular Evaluation (TIME) Trial™ Program...

University of Pittsburgh Joins Disruptive AI-based Federated Learning Network to Advance Clinical Research

The University of Pittsburgh has partnered with AI and Federated Learning technologies startup to help augment medical research and enable scientific discoveries. In first establishing a pilot agreement, the University of Pittsburgh will leverage its own high-quality...

Toronto’s AI-vendor Cyclica Inks Strategic Collaboration with Elite Chinese Academic Research Center targeting COVID-19

One of China’s premier government-backed, elite academic research institutions, Institute of Materia Medica, Chinese Academy of Medical Sciences, entered into a strategic research collaboration with a small Canadian-based biotech upstart called Cyclica to discovery...

Improving Clinical Trial Participant Prescreening With Artificial Intelligence (AI): A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials

Delays in clinical trial enrollment and difficulties enrolling representative samples continue to vex sponsors, sites, and patient populations. Physician’s Weekly reports on an investigated use of an artificial intelligence-powered technology, Mendel.ai, as a means of...